Mounjaro and Acid Reflux: Causes, Relief, and When to Seek Help

Mounjaro (tirzepatide) is a prescription weight loss injection and treatment for type 2 diabetes that works by targeting two important hormone pathways involved in appetite, digestion and blood glucose control. As a GLP-1 receptor agonist and GIP receptor agonist, Mounjaro is classed as a dual agonist because it activates receptors linked to both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).

Although Mounjaro can help eligible patients achieve weight loss and improve metabolic health, some people experience digestive side effects during treatment. Acid reflux and heartburn are among the symptoms that may occur, alongside indigestion, dyspepsia, acid regurgitation, excessive burping and eructation.

This article explains why Mounjaro (tirzepatide) may cause acid reflux and heartburn. It covers the causes behind these symptoms, including delayed gastric emptying, changes in appetite and increased stomach pressure. It also explores symptom relief options, including diet changes, lifestyle changes, pharmacy treatments and when to seek medical help from a GP or NHS 111.

The article will also explain how common reflux symptoms are during Mounjaro treatment, when symptoms are most likely to occur, whether they usually improve over time and how Mounjaro compares with other weight management injections.

Acid reflux happens when stomach acid moves upwards into the oesophagus, causing symptoms such as a burning sensation in the chest, a sour taste, acid regurgitation or discomfort after eating. Some people may experience symptoms similar to gastro-oesophageal reflux disease (GORD), which is the medical term for ongoing reflux that affects daily life. Other digestive symptoms associated with Mounjaro include indigestion, dyspepsia, bloating and eructation.

The Mounjaro patient information leaflet lists gastro-oesophageal reflux disease, eructation and abdominal distension as common side effects. A common side effect means it may affect between 1 in 100 and 1 in 10 people taking the medicine [1].

Real-world reports of reflux and indigestion with tirzepatide have also identified gastro-oesophageal reflux disease and dyspepsia as two of the strongest gastrointestinal adverse-event signals associated with treatment [2].

These symptoms are often linked to the way tirzepatide affects digestion. Mounjaro can delay gastric emptying, meaning food remains in the stomach for longer. This effect may be more noticeable during treatment initiation and dose escalation when the body is adjusting to different doses through the process of dose titration.

In One Sentence:

Acid reflux and heartburn are recognised side effects of Mounjaro (tirzepatide) that are often mild and short-lived, with symptoms usually managed through diet changes, lifestyle changes and pharmacy antacids while red-flag symptoms should be discussed with a GP or NHS 111.

Key Takeaways

• Does Mounjaro cause acid reflux? 

Yes, acid reflux is a recognised common side effect of Mounjaro, with heartburn, indigestion and burping linked to changes in digestion caused by tirzepatide.

• Why does Mounjaro cause reflux? 

Tirzepatide can delay gastric emptying, which may increase stomach pressure and make it easier for stomach acid to move upwards past the lower oesophageal sphincter, also known as the stomach valve.

• How common is acid reflux on Mounjaro? 

Acid reflux and related symptoms are classified as common side effects, affecting between 1 in 100 and 1 in 10 people, with some clinical trials reporting around a 2 in 100 incidence rate.

• When is Mounjaro reflux usually the worst? 

Symptoms are often more noticeable during the first few weeks of treatment or after a dose increase, such as moving from 2.5mg to 5mg, before the body adapts.

• How can Mounjaro heartburn be eased? 

Smaller meals, avoiding trigger foods, staying upright after eating and using suitable treatments such as antacids or alginates like Gaviscon may help relieve symptoms, but urgent medical advice is needed for symptoms such as difficulty swallowing, vomiting blood, black tarry stools, severe abdominal pain or chest pain.

Why does Mounjaro cause heartburn and indigestion?

Mounjaro can cause heartburn and indigestion because tirzepatide changes digestive activity by slowing stomach emptying and affecting gut hormone signalling.

Tirzepatide is a dual GIP receptor agonist and GLP-1 receptor agonist. These medicines work by mimicking the activity of incretin hormones, which are naturally produced by the digestive system.

Glucose-dependent insulinotropic polypeptide (GIP) is produced by K-cells in the upper small intestine, while glucagon-like peptide-1 (GLP-1) is produced by L-cells in areas including the ileum. These gut hormones influence appetite, insulin release and digestion.

When Mounjaro activates these pathways, it can increase feelings of satiety and reduce appetite. These effects contribute to weight loss but can also affect how quickly food moves through the stomach.

One of the main reasons people experience reflux symptoms while taking Mounjaro is delayed gastric emptying. Research into how tirzepatide slows gastric emptying shows that the effect is temporary, dose-dependent and strongest after the first exposure to treatment [3].

When stomach emptying slows, food and stomach acid may remain in the stomach for longer. This can increase intragastric pressure, which may encourage reflux, particularly if the lower oesophageal sphincter (LOS) does not fully prevent stomach contents from moving back into the oesophagus.

This can contribute to symptoms including:

• Heartburn

• Acid reflux

• Acid regurgitation

• Bloating

• Indigestion

• Dyspepsia

• Mounjaro burps or frequent eructation

Some people notice these symptoms after meals because a slower digestive process can make the stomach feel fuller more quickly. Early satiety, which means feeling full after eating a smaller amount of food, is a common effect of medicines that act on GLP-1 pathways.

The relationship between dose increases and reflux symptoms is also important. Stomach emptying is most delayed after the first dose and then becomes less affected over time as the body adapts. This process is known as tachyphylaxis. The effect can happen again after each dose increase as treatment is stepped up [4].

The Mounjaro PIL also confirms that tirzepatide delays gastric emptying, with the greatest delay occurring after the first dose and reducing over time [1].

For some people, reflux symptoms may flare during dose titration periods, such as when increasing from 2.5mg to 5mg or moving to higher doses. This does not necessarily mean Mounjaro is unsuitable, but symptom management may be needed during these adjustment periods.

Simple measures such as eating smaller meals, avoiding personal trigger foods and not lying down soon after eating may help reduce reflux symptoms while the body adjusts to treatment. Anyone experiencing ongoing or troublesome symptoms should speak with their prescriber for personalised advice.

"Heartburn is one of the digestive side effects some people notice when starting Mounjaro or increasing their dose. The medicine slows stomach emptying as part of the way it helps control appetite and blood sugar, but that same effect can allow stomach contents to remain in the stomach for longer and make reflux symptoms more noticeable. For most people, these symptoms improve as the body adapts, particularly if they eat smaller meals and follow the recommended dose increases."

How common is acid reflux on Mounjaro (tirzepatide)?

Acid reflux is a common side effect of Mounjaro (tirzepatide), but most gastrointestinal symptoms reported during treatment are mild to moderate and often improve as the body adjusts.

The patient information leaflet for Mounjaro classifies gastro-oesophageal reflux disease (GORD), eructation and abdominal distension as common side effects. This frequency classification means these symptoms may affect between 1 in 100 and 1 in 10 people, which is equivalent to 1% to 10% of patients [1].

Clinical trials have shown that gastrointestinal side effects are among the most frequently reported reactions with tirzepatide. However, many of these effects are temporary and are most commonly experienced during dose escalation, when the dose is gradually increased to reach the maintenance dose [5].

The digestive side effects associated with Mounjaro can include:

• Nausea, which is classed as a very common side effect affecting more than 1 in 10 people

• Diarrhoea, which is also classed as very common

• Vomiting

• Constipation

• Abdominal pain

• Dyspepsia (indigestion)

• Eructation (burping)

• Abdominal distension (bloating)

• Gastro-oesophageal reflux disease (GORD)

In clinical studies, reflux symptoms occurred less frequently than some other digestive side effects. The Mounjaro SmPC reports that GORD occurred in around 2 in 100 patients in some trial groups, although the exact frequency can vary depending on the dose and patient population studied [1].

Research from the SURPASS clinical trial programme found that gastrointestinal adverse events with tirzepatide were generally mild to moderate. These effects were more likely to appear during dose escalation and were usually temporary [5]. Similar findings were observed in the SURMOUNT obesity trials, where gastrointestinal events such as dyspepsia were mostly mild to moderate, commonly occurred around dose increases and did not prevent continued weight loss [6].

Real-world analysis has also highlighted reflux and dyspepsia as important gastrointestinal signals linked with tirzepatide use. These reports reflect experiences from broader groups of patients outside clinical trials and support the importance of monitoring digestive symptoms during treatment [7].

It is important to remember that experiencing acid reflux does not necessarily mean that Mounjaro is unsuitable. Many people find that symptoms are strongest during the first few weeks of treatment or after increasing their dose and then improve as their digestive system adapts.

If reflux symptoms become persistent, severe or interfere with everyday life, patients should speak with their healthcare provider, prescriber or pharmacist for advice.

How can I stop heartburn and acid reflux while taking Mounjaro?

Mild heartburn while taking Mounjaro can often be managed with practical lifestyle changes, adjustments to eating habits and suitable over-the-counter treatments.

Because tirzepatide can slow digestion, some people find that their usual meal sizes become uncomfortable. Making changes to meal timing, portion sizes and food choices can reduce pressure on the stomach and help limit reflux symptoms.

Diet and Lifestyle Changes That Help

Small changes to daily habits can help reduce acid reflux symptoms while taking Mounjaro.

Eating smaller, more frequent meals may help because large meals can overfill the stomach and increase pressure inside the abdomen. This is particularly relevant for people experiencing early satiety or increased fullness from Mounjaro.

Helpful strategies include:

• Eating smaller portions and stopping at the first sign of fullness

• Staying upright for 2 to 3 hours after eating

• Avoiding bending over or lying down soon after meals

• Finishing the last meal of the day at least 3 hours before going to bed

• Raising the head of the bed by around 10 to 20cm if reflux occurs at night

• Reducing foods and drinks that personally trigger symptoms

• Stopping smoking if you smoke

The NHS recommends raising the head of the bed by around 10 to 20cm using blocks, bricks or books placed under the bed legs. Using extra pillows is not recommended because this can increase pressure on the abdomen and potentially worsen reflux symptoms [8].

Common dietary triggers for acid reflux can include:

• Fatty foods

• Fried foods

• Spicy foods

• Chocolate

• Peppermint

• Citrus fruits and juices

• Tomatoes

• Onions

• Caffeine

• Fizzy drinks and carbonated drinks

• Alcohol

These foods do not trigger symptoms for everyone, so identifying personal triggers can be more useful than avoiding a large number of foods unnecessarily.

Weight loss itself may also improve reflux symptoms over time. Research into lifestyle changes for acid reflux found that weight loss reduced oesophageal acid exposure in randomised trials, while stopping smoking was associated with reduced reflux symptoms in a large cohort study [9].

The reason weight loss can improve reflux is that excess weight can increase pressure inside the abdomen, making it easier for stomach contents to move upwards into the oesophagus.

Pharmacy and Prescription Treatments for Reflux

Pharmacy treatments can help manage reflux symptoms while taking Mounjaro, but the right option depends on how often symptoms occur and their severity.

Antacids such as Rennie work by neutralising stomach acid and may provide short-term relief from occasional heartburn. Alginates such as Gaviscon and Gaviscon Advance work differently by creating a protective raft that sits above stomach contents, helping form an acid barrier that reduces reflux into the oesophagus.

Other medicines may be recommended by a healthcare professional if symptoms are more frequent, including:

H2-receptor antagonists such as famotidine, which reduce stomach acid production

Proton pump inhibitors (PPIs) such as omeprazole or lansoprazole, which provide stronger gastric acid suppression

The NHS advises that antacids are best taken with or soon after food. However, they do not cure the underlying cause of reflux and should not usually be taken regularly for long periods without medical advice. A GP may prescribe a proton pump inhibitor if symptoms require longer-term treatment [8].

A pharmacist can help advise on suitable over-the-counter options and check for possible drug interactions. A prescriber can review whether additional treatment is appropriate alongside Mounjaro.

Patients should not stop Mounjaro or change their dose without medical advice. If reflux symptoms appear after a dose increase, a prescriber may be able to discuss symptom management options or whether the current treatment plan remains appropriate.

"Managing reflux while taking Mounjaro is usually about controlling symptoms rather than stopping treatment. Simple lifestyle measures combined with the right pharmacy treatment are often enough for occasional heartburn, while people with more persistent symptoms may benefit from a review with their prescriber. The important thing is not to change or stop your Mounjaro dose without medical advice."

How does Mounjaro reflux compare with other weight loss injections?

Mounjaro reflux symptoms are similar to digestive side effects seen with other medicines in the GLP-1 class, although Mounjaro has a unique mechanism because it is a GIP and GLP-1 dual agonist.

Weight management injections including Mounjaro (tirzepatide), Wegovy (semaglutide) and Saxenda (liraglutide) can affect digestion because they influence gut hormone pathways involved in appetite and stomach emptying.

Mounjaro contains tirzepatide, which activates both GIP and GLP-1 receptors. Wegovy contains semaglutide, which is a GLP-1 receptor agonist. Saxenda contains liraglutide, which is also a GLP-1 receptor agonist but is a shorter-acting daily treatment.

Because these medicines affect digestion, symptoms can occur across the treatment class, such as:

• Reflux

• Dyspepsia

• Nausea

• Fullness

• Bloating

The Mounjaro SmPC classifies reflux as a common side effect occurring between 1 in 100 and 1 in 10 patients [1]. Research also shows that tirzepatide’s effect on gastric emptying is temporary, with the strongest slowing effect occurring after initial exposure and reducing over time [3].

The NHS also notes that being overweight can increase pressure on the stomach and encourage reflux, meaning weight loss may help reduce symptoms for some people over the longer term [8].

A head-to-head trial comparing tirzepatide and semaglutide found that gastrointestinal adverse events were the most common side effects in both groups. However, gastrointestinal side effects leading to treatment discontinuation were reported more frequently with semaglutide than tirzepatide in the study population [10].

The experience of reflux can vary significantly between individuals. Factors such as existing digestive conditions, eating habits, dose increases and personal sensitivity to changes in stomach emptying can all influence symptoms.

Does acid reflux from Mounjaro go away?

Acid reflux from Mounjaro often improves over time as the body adapts to tirzepatide, although symptoms can return temporarily during treatment initiation or after a dose increase.

When starting Mounjaro, the digestive system needs time to adjust to changes caused by GLP-1 and GIP receptor activation. The medicine can slow gastric emptying, meaning food remains in the stomach for longer. This effect is usually strongest after the first dose and gradually becomes less noticeable as the body develops tolerance.

The Mounjaro PIL confirms that the delay in gastric emptying is largest after the first dose and diminishes over time [1].

This adaptation process may explain why some people experience reflux symptoms during the first few weeks of treatment but find that symptoms become less noticeable later. The same pattern may occur after dose increases because the digestive system is exposed to a stronger effect again during titration.

However, symptom improvement is not guaranteed for everyone. Some people may continue to experience acid reflux, heartburn or indigestion throughout treatment, particularly if they have other risk factors for reflux such as:

• A history of gastro-oesophageal reflux disease (GORD)

• Large meal portions

• Eating close to bedtime

• Foods that trigger reflux symptoms

• Increased abdominal pressure linked to excess weight

Weight loss itself may have a positive effect on reflux symptoms. Excess weight can increase pressure within the abdomen, making it easier for stomach contents to move upwards into the oesophagus.

A large population study involving around 29,610 people found that weight loss was associated with reduced reflux symptoms and improved success with anti-reflux medication [11].

Research into structured weight loss programmes has also shown improvements in reflux symptoms. In one study of 332 adults, 81% experienced reduced reflux symptoms after six months and 65% achieved complete resolution [12].

This means that while acid reflux may occur as a short-term side effect during Mounjaro treatment, the longer-term effects of weight loss may help reduce reflux risk for some people.

Patients should continue following their prescribed treatment plan and discuss ongoing symptoms with their healthcare professional. Persistent reflux, worsening symptoms or symptoms that affect daily activities may require further assessment.

When is heartburn on Mounjaro a sign of something serious?

Most cases of heartburn linked with Mounjaro are mild and temporary, but certain symptoms can indicate the need for medical assessment.

Acid reflux is common and is usually not dangerous, but severe reflux symptoms or unusual changes should not be ignored. Patients taking Mounjaro should be aware of heartburn red flags that may require help from a GP, NHS 111 or emergency services.

See a GP or contact NHS 111 if you have:

• Heartburn most days for three weeks or more

• Pharmacy medicines that are not helping

• Difficulty swallowing (dysphagia)

• A feeling that food is getting stuck when swallowing

• Frequent vomiting

• Unexplained weight loss

• Painful swallowing

• Ongoing or worsening reflux symptoms

The NHS advises speaking with a GP if heartburn occurs most days for three weeks or more, if food becomes stuck when swallowing, if you are frequently sick or if you lose weight without explanation [8].

If symptoms worsen or you are unsure what to do, NHS 111 online or NHS 111 can provide advice about the next steps [13].

Get urgent help by calling 999 or going to A&E if you have:

• Severe chest pain

• Crushing chest pain

• Pain spreading to the arm, jaw, neck or back

• Symptoms that could suggest cardiac chest pain or a heart problem

• Vomiting blood (haematemesis)

• Black tarry stools (melaena)

• Severe abdominal pain

Chest pain should always be taken seriously because symptoms from reflux can sometimes feel similar to symptoms of heart-related conditions.

Patients taking medicines in the GLP-1 class should also be aware of rare but serious complications. The Mounjaro SmPC includes acute pancreatitis as a warning associated with tirzepatide. Severe abdominal pain, particularly pain that radiates to the back, should receive urgent medical assessment [1].

Anyone who experiences suspected medicine side effects can report them through the MHRA Yellow Card Scheme. This UK reporting system helps monitor the safety of medicines and identify possible safety concerns.

"Most reflux symptoms linked with Mounjaro are mild and temporary, but persistent heartburn or symptoms such as difficulty swallowing, vomiting blood or severe chest or abdominal pain should never be ignored. Knowing the difference between expected digestive side effects and warning signs that need urgent medical assessment helps people use Mounjaro safely and seek the right care at the right time."

Frequently Asked Questions

Is acid reflux a sign that Mounjaro is working?

Acid reflux is a side effect of Mounjaro and is not a sign that the medicine is working.

While delayed gastric emptying can contribute to reflux symptoms, the effectiveness of Mounjaro depends on factors such as the prescribed dose, treatment adherence and individual response. Weight loss results are not measured by whether someone experiences heartburn or indigestion.

A person can experience reflux while taking Mounjaro without achieving weight loss, and another person can achieve successful weight loss without experiencing reflux symptoms.

Can I take Gaviscon or omeprazole with Mounjaro?

Gaviscon and omeprazole can often be used alongside Mounjaro, but patients should check with a pharmacist or prescriber before starting any new medicine.

Mounjaro is a subcutaneous injection, while medicines such as Gaviscon and omeprazole work in the digestive system after being taken by mouth. There are no known direct interactions that prevent their use together for most people, but individual circumstances vary.

Antacids such as Gaviscon are generally taken with or after food to help provide relief. Omeprazole and other proton pump inhibitors may be recommended when longer-lasting acid suppression is needed.

A pharmacist can advise on appropriate timing, possible drug interactions and whether short-term or longer-term treatment is suitable.

Does Mounjaro cause reflux at night?

Mounjaro can contribute to nocturnal reflux symptoms in some people, particularly when delayed stomach emptying combines with lying down after eating.

When a person lies flat, gravity no longer helps keep stomach contents lower in the digestive system. This can make it easier for acid to move into the oesophagus, especially after a large meal or eating shortly before sleep.

Helpful strategies for night-time reflux include:

• Avoiding food for around three hours before bedtime

• Staying upright after your evening meal

• Raising the head of the bed by around 10 to 20cm

• Avoiding foods that trigger evening symptoms

Using extra pillows is not usually recommended because this can increase abdominal pressure and may worsen reflux.

Will lowering my Mounjaro dose stop the reflux?

Reducing the Mounjaro dose may help some people who experience reflux after a dose increase, but any dose adjustment should only be discussed with a prescriber.

Symptoms may appear more strongly during titration because the digestive system is adapting to a higher amount of tirzepatide. A healthcare professional can review symptom severity, treatment goals and whether dose adjustment or additional symptom management is appropriate.

Patients should not reduce their dose or stop Mounjaro without medical advice.

How long does Mounjaro heartburn usually last?

Mounjaro heartburn can last from several days to several weeks, depending on the individual and whether symptoms occur during treatment initiation or after a dose increase.

Many people find that symptoms improve as their body adapts to tirzepatide. However, persistent symptoms lasting three weeks or more, worsening reflux or symptoms affecting quality of life should be reviewed by a GP or prescriber.

Can Mounjaro make existing GORD worse?

Mounjaro may temporarily worsen existing GORD symptoms in some people, especially during the early weeks of treatment or after dose increases.

Patients with a history of gastro-oesophageal reflux disease should tell their prescriber before starting treatment. This allows healthcare professionals to consider previous symptoms, current medicines and ways to reduce the chance of reflux becoming troublesome.

Final Thoughts From Our Clinical Team

“Acid reflux can be an uncomfortable but recognised mild side effect of Mounjaro treatment, particularly during the first few weeks after starting tirzepatide or following a dose increase. Because Mounjaro can slow delayed gastric emptying, some people may experience symptoms such as heartburn, indigestion, fullness, burping or reflux while their body adjusts.

For many patients, simple steps can help manage symptoms. Eating smaller meals, stopping when feeling full, avoiding personal trigger foods, staying upright after eating and raising the head of the bed can all support better reflux control. Pharmacy treatments such as antacids and alginates, including Gaviscon, may provide relief when appropriate.

Over the longer term, weight loss achieved through Mounjaro may help reduce reflux symptoms for some people because excess weight can increase pressure on the stomach and contribute to gastro-oesophageal reflux disease (GORD). However, symptoms should not be ignored if they become severe, persistent or unusual.

Patients should seek medical advice if they experience warning signs such as dysphagia (difficulty swallowing), haematemesis (vomiting blood), melaena (black tarry stools), severe chest pain or severe abdominal pain. These symptoms may require urgent assessment.

Anyone experiencing ongoing reflux while taking Mounjaro should speak with their prescriber or healthcare professional.”

Sources

[1] Mounjaro KwikPen 15mg solution for injection in pre-filled pen PIL

[2] A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database

[3] Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic

[4] The impact of tirzepatide and glucagon-like peptide 1 receptor agonists on oral hormonal contraception - Journal of the American Pharmacists Association

[5] Gastrointestinal adverse events and weight reduction in people with type 2 diabetes treated with tirzepatide in the SURPASS clinical trials - Patel - 2024

[6] Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT‐1 to ‐4 trials

[7] A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database  

[8] Heartburn and acid reflux - NHS

[9] Lifestyle Intervention in Gastroesophageal Reflux Disease - Clinical Gastroenterology and Hepatology

[10] Tirzepatide as Compared with Semaglutide for the Treatment of Obesity | New England Journal of Medicine

[11] Weight Loss and Reduction in Gastroesophageal Reflux. A Prospective Population-Based Cohort Study: The HUNT Study - AJG

[12] Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: A prospective intervention trial - Singh - 2013 - Obesity - Wiley Online Library

[13] NHS 111